Granules India Ltd
Ticker: GRANULES
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
565.60
Market Cap
13725.34
Debt/Equity
0.3915
ROE %
14.451
PB
3.6940
Promoter %
38.820
Pledge %
0.000
1Y Rev Growth %
0.322
5Y Rev Growth %
10.976
NP Margin %
11.083
NP Margin 5Y Avg %
11.845
Trading Reference
1M Return %
9.872
6M Return %
24.144
1Y Return %
-0.702
% Away 52W High
11.033
% Away 52W Low
34.028
Daily Volume
384397
Investment Verdict
Hold
Score 64/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Momentum
Score 73/100 · Position size: 20%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
More Options
J
Jaiprakash Power Ventures Ltd
Jaiprakash Power Ventures Ltd presents several risks with inconsistent growth and profitability metrics, high debt levels, and weak technicals, making it a risky investment.
View details
F
Finolex Cables Ltd
Finolex Cables Ltd shows potential for growth, but faces challenges in profitability and valuation. Investors should proceed with caution.
View details
A
Aavas Financiers Ltd
Aavas Financiers Ltd shows decent potential with consistent growth and a strong business model, but valuation concerns and cash flow issues warrant caution.
View details
V
Vikram Solar Ltd
Vikram Solar Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
C
Cube Highways Trust
Cube Highways Trust shows potential for growth but faces several challenges that could impact its performance.
View details
I
Indian Energy Exchange Ltd
The stock shows potential but faces challenges in profitability and valuation metrics. Caution is advised.
View details
R
RITES Ltd
RITES Ltd shows potential for growth in a favorable sector, but investors should be cautious of execution risks and market volatility.
View details
K
Kirloskar Oil Engines Ltd
Kirloskar Oil Engines Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
M
Mahanagar Gas Ltd
Mahanagar Gas Ltd shows potential for growth in a promising sector, but faces challenges in profitability and execution risks.
View details
B
Belrise Industries Ltd
Belrise Industries Ltd shows potential but faces significant risks that may impact future performance.
View details
E
Embassy Developments Ltd
Embassy Developments Ltd shows potential for growth, but faces challenges in profitability and market conditions. Investors should proceed with caution.
View details
A
Anupam Rasayan India Ltd
Anupam Rasayan India Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Investors should be cautious and monitor execution risks closely.
View details
T
Titagarh Rail Systems Ltd
Titagarh Rail Systems Ltd shows potential in a critical sector but faces challenges in growth consistency and market valuation.
View details
N
Newgen Software Technologies Ltd
Newgen Software Technologies Ltd shows potential for growth but faces challenges in valuation and execution risks.
View details
B
Blue Jet Healthcare Ltd
Blue Jet Healthcare Ltd shows potential for growth but faces significant challenges in profitability and execution risks.
View details
V
Vardhman Textiles Ltd
Vardhman Textiles shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
Business Overview
Granules India Ltd is a prominent player in the Indian pharmaceutical sector, specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. Catering to both domestic and international markets, Granules is committed to quality and innovation, making it a trusted partner for healthcare companies worldwide. With a focus on sustainability and efficiency, the company plays a vital role in ensuring affordable healthcare solutions.
- Established leader in pharmaceutical manufacturing
- Wide range of APIs and finished dosage forms
- Strong domestic and international presence
- Commitment to quality and innovation
- Focus on sustainability and cost efficiency
Investment Thesis
Granules India Ltd stands out due to its credible promoter group, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for sustainable growth and value creation, making it a strong candidate for investment.
- Promoter group with a strong track record and credibility enhances investor confidence.
- Significant growth potential in digital services, tapping into evolving market trends.
- Attractive valuation metrics compared to industry peers, offering a favorable entry point.
- Established operational efficiency and cost leadership in the pharmaceutical sector.
- Strong financial performance with consistent revenue and profit growth.
Opportunity vs Risk
Opportunities
- Strong revenue growth potential
- Expanding product portfolio
- Rising demand for generics
- Strategic partnerships in healthcare
- Favorable government policies
Risks ⚠️
- Regulatory compliance challenges
- Intense market competition
- Currency fluctuation impacts
- Supply chain disruptions
- Rising raw material costs
Peer Perspective
Granules India Ltd trades at a discount to peers like Aarti Drugs and Divi's Laboratories, reflecting concerns over margin stability. A sustained improvement in operational efficiency could trigger a rerating in its valuation.
Future Outlook
Granules India Ltd is well-positioned for growth, driven by strong demand for its products. However, successful execution of its expansion plans and stringent cost control will be crucial to achieving its long-term potential.
AI FAQs for Retail Users
- Q: What does Granules India Ltd do?A: Granules India Ltd is a pharmaceutical company that manufactures generic drugs and active pharmaceutical ingredients.
- Q: Is Granules India Ltd a good investment?A: Investment suitability depends on individual financial goals and risk tolerance; consider researching before investing.
- Q: What are the main products of Granules India Ltd?A: The company produces formulations, APIs, and over-the-counter products for various therapeutic areas.
- Q: How has Granules India Ltd performed recently?A: Recent performance can vary; check financial news and reports for the latest updates.
- Q: Where can I find more information about Granules India Ltd?A: Visit the company's official website or refer to financial news platforms for detailed information.
📊 Stock Investment Checklist (100 Points)
Granules India Ltd • Updated: 2025-09-17 06:46:56
-
10BusinessHighPharmaceutical sector is growing, but competition is intense.
-
10GrowthHighConsistent revenue growth, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
8ValuationHighValuation metrics are in line with peers, but not compelling.
-
7BalanceHighModerate debt levels, liquidity is acceptable.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Granules India Ltd shows potential for growth but faces challenges in profitability and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 60/100
- Market Confidence: 68/100